Evidence map›Paper›PMID 41180342›Full record

ArticleCJC open2025

The Ottawa Mobile Screening Program-Concept and First 18 Months of Experience with a Community-Based Outreach Cardiovascular Prevention Program.

Katherine Kelemen-Dagg, Sandra Wong, Haley Emmerson, Ruth Coulton, Ryan Milne, Roja Gauda, Ademola Opapeju, Douaa Swar, Aimee Large, Samantha Kolupanowicz and 18 more

Abstract read
In one paragraph

Article in CJC open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Katherine Kelemen-DaggDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Sandra WongDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Haley EmmersonDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ruth CoultonDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ryan MilneDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Roja GaudaDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ademola OpapejuEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Douaa SwarEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Aimee LargeEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Samantha KolupanowiczEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Megan KirkpatrickEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kaleki HillEchocardiography Laboratory, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kerri-Anne MullenDivision of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Christele FerryDivision of Cardiac Prevention and Rehabilitation, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kednapa ThavornOttawa Hospital Research Institute, The Ottawa Hospital; School of Epidemiology and Public Health, University of Ottawa, Ottawa, Ontario, Canada.
Gary SmallDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Vincent ChanDivision of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Donna JustusDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kelsey OldlandDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Kate MacdonaldDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Ian G BurwashDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Erika MacpheeDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
David BirnieDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Rob BeanlandsDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Gaspard SucDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Thierry MesanaDivision of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
Cindy CrossDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
David Messika-ZeitounDivision of Cardiology, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: There is a critical need to implement new strategies to combat cardiovascular (CV) disease and more specifically valvular heart disease (VHD). We hypothesize that a community-based, outreach, mobile screening program offering convenient screening for VHD using handheld cardiac ultrasound is feasible. and capable of facilitating early diagnosis and referral in a substantial proportion of patients. We aimed to present our experience and results from the first 18 months of implementation of the program. Methods: We included individuals aged ≥ 65 years with no known CV disease, residing in Ottawa and its surrounding region (within Canada). We took the opportunity to combine CV risk factor assessment with VHD screening. Potential abnormal findings were triaged according to a predefined algorithm, including an automatic referral process. Results: We screened 1817 participants (aged 75 ± 7 years; 70% female) during 109 clinics held at 57 different locations between May 2023 and October 2024. VHD abnormalities were observed in 125 participants (7%), and nonvalvular echocardiographic abnormalities were observed in 163 participants (9%). Taking advantage of VHD screening, we identified elevated blood pressure, cholesterol level, or hemoglobin A1C level in 505 participants (28%), with 77% of these cases being newly diagnosed/untreated. Participants with VHD were referred to our valve centre; others were advised to contact their primary care provider or a walk-in clinic for appropriate follow-up care. Conclusions: In this innovative prevention initiative, we demonstrate the feasibility of an outreach mobile screening program, revealing relatively high rates of VHD, nonvalvular abnormalities, and uncontrolled risk factors. These findings highlight the program's potential to substantially enhance population health outcomes.

Indexed as

cardiovascular risk factorsechocardiographypreventative healthcarescreeningValvular heart disease

Identifiers

PMID41180342
PMCPMC12572886

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.